1. How do you ensure regulatory compliance while writing a Clinical Study Report (CSR)?
Answer:
→ Review ICH E3 guideline and sponsor’s SOPs first → Map all study data (protocol, SAP, safety tables) → Perform QC check for consistency between sections → Get medical & statistical review before finalization.
2. What is the difference between ICH E3 and ICH E6 in medical writing context?
Answer:
→ ICH E3 provides structure and content for CSRs → ICH E6 focuses on Good Clinical Practice (GCP) principles for conduct and documentation → Always align CSR with both for regulatory acceptance.
3. How do you handle conflicting data between safety and efficacy sections in a CSR?
Answer:
→ Cross-check raw data and statistical outputs → Discuss with Medical Monitor & Biostatistician → Document the discrepancy with clear justification → Maintain consistent narrative across all sections.
4. Explain the process of writing a Protocol Synopsis for regulatory submission.
Answer:
→ Start with study objectives and design → Include key inclusion/exclusion criteria, endpoints, and statistical methods → Keep language clear, concise and consistent with full protocol → Get sponsor & regulatory review.
5. What are the key components of a high-quality Investigator’s Brochure (IB)?
Answer:
→ Non-clinical & clinical data summary → Risk-benefit assessment → Detailed safety information → Clear dosing & monitoring recommendations → Update as per latest data.
6. How do you write effective narratives for Serious Adverse Events (SAEs)?
Answer:
→ Follow company template and CIOMS format → Present chronological events with accurate medical terminology → Highlight causality assessment → Ensure consistency with safety database.
7. What is the importance of consistency in medical writing documents?
Answer:
→ Maintain uniform terminology, abbreviations, and formatting across protocol, CSR, and publications → Prevents regulatory queries → Builds credibility → Reduces review cycles.
8. How do you approach writing a publication manuscript from a CSR?
Answer:
→ Select target journal and follow CONSORT/GPP guidelines → Focus on key primary & secondary endpoints → Shorten detailed safety data → Emphasize clinical significance and novelty.
9. Explain risk-based monitoring in the context of medical writing.
Answer:
→ Highlight critical data points and risks in the monitoring plan → Write clear instructions for sites and monitors → Ensure documentation supports risk-based approach as per ICH E6(R2).
10. How do you manage tight timelines while maintaining quality in medical writing deliverables?
Answer:
→ Create a detailed timeline with review cycles → Prioritize sections based on regulatory importance → Use templates and track changes effectively → Schedule parallel reviews with stakeholders.